title: Fulminant hepatic failure after high-dose cytosine arabinoside and mitoxantrone treatment for relapse of acute myelogenous leukaemia.
authors: K
authors: K
authors: Nachbaur
authors: O
authors: O
authors: Dietze
authors: M
authors: M
authors: Herold
authors: J
authors: J
authors: Thaler
authors: H
authors: H
authors: Braunsteiner
authors: W
authors: W
authors: Vogel
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects*; D003630:Daunorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008099:Liver / Q000473:pathology; D017114:Liver Failure, Acute / Q000139:chemically induced* / Q000473:pathology; D008942:Mitoxantrone / Q000008:administration & dosage / Q000009:adverse effects*; D009336:Necrosis; D012008:Recurrence; D013866:Thioguanine / Q000008:administration & dosage
chemical_list: D003561:Cytarabine; D008942:Mitoxantrone; D013866:Thioguanine; D003630:Daunorubicin